Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

328
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
328
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

263
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
263
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

414
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
414
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

358
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
358
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

217
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
217
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

339
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
339

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bloating During the Menopause Transition: Observations from the Seattle Midlife Women's Health Study.

Journal of women's health (2002)·2026
Same author

Relationship Between Heart Rate Variability and Sleep Among Girls and Boys With Abdominal Pain-Related Disorders of Gut-Brain Interaction.

Neurogastroenterology and motility·2026
Same author

Sleep Characteristics and Cognitive Symptoms Among Adults with Inflammatory Bowel Disease.

Clinical nursing research·2026
Same author

Menopause and Inflammatory Bowel Disease: A Systematic Review.

Inflammatory bowel diseases·2025
Same author

First Real-World Evidence of an AI-Enhanced Digital Collaborative Care Model to Improve IBS Symptoms.

Neurogastroenterology and motility·2025
Same author

Examining Mediating Factors in the Relationship Between Sleep Disturbance and Symptoms in Adults with Inflammatory Bowel Disease.

Clinical nursing research·2025

Related Experiment Video

Updated: Sep 30, 2025

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling
06:04

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

Published on: January 17, 2025

791

Cognitive Behavioral Therapy-Based Comprehensive Self-Management Program Improves Presenteeism in Persons with

Pei-Lin Yang1, Sarah W Matthews2, Robert L Burr3

  • 1School of Nursing, National Defense Medical Center, Taipei 114, Taiwan.

International Journal of Environmental Research and Public Health
|March 10, 2022
PubMed
Summary

A comprehensive self-management (CSM) program significantly improved work productivity and reduced activity impairment in individuals with irritable bowel syndrome (IBS). These benefits were sustained for up to 12 months, offering advantages for both patients and society.

Keywords:
functional gastrointestinal disorderoccupational rehabilitationwork productivity loss

More Related Videos

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.4K
Mindfulness in Motion MIM: An Onsite Mindfulness Based Intervention MBI for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement
12:22

Mindfulness in Motion MIM: An Onsite Mindfulness Based Intervention MBI for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement

Published on: July 1, 2015

23.8K

Related Experiment Videos

Last Updated: Sep 30, 2025

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling
06:04

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling

Published on: January 17, 2025

791
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.4K
Mindfulness in Motion MIM: An Onsite Mindfulness Based Intervention MBI for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement
12:22

Mindfulness in Motion MIM: An Onsite Mindfulness Based Intervention MBI for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement

Published on: July 1, 2015

23.8K

Area of Science:

  • Gastroenterology
  • Occupational Health
  • Behavioral Medicine

Background:

  • Irritable bowel syndrome (IBS) significantly impacts work productivity through absenteeism, presenteeism, and activity impairment.
  • Existing treatments for IBS often focus on symptom management, with less emphasis on work-related functional outcomes.

Purpose of the Study:

  • To compare the effectiveness of a comprehensive self-management (CSM) intervention against usual care in mitigating work and activity impairments in adults with IBS.
  • To assess the sustained impact of the CSM intervention on productivity and daily functioning over 12 months.

Main Methods:

  • A secondary data analysis of 160 adults with IBS using daily diaries and the Work Productivity and Activity Impairment in Irritable Bowel Syndrome (WPAI-IBS) questionnaire.
  • Data collected at baseline, 3, 6, and 12 months post-randomization.
  • Mixed-effects modeling employed to compare CSM intervention effects versus usual care.

Main Results:

  • The CSM intervention demonstrated superior improvements in WPAI-IBS scores and diary-measured presenteeism compared to usual care.
  • Significant reductions in overall work productivity loss and activity impairment were observed with the CSM intervention.
  • These positive effects on work and activity impairments were sustained up to 12 months post-intervention (p < 0.05).

Conclusions:

  • A comprehensive self-management intervention is effective in improving work productivity and reducing activity impairments in individuals with IBS.
  • The CSM intervention offers sustained benefits, suggesting its value in managing the functional consequences of IBS.
  • The intervention showed particular benefit for IBS patients experiencing greater baseline work and activity limitations, highlighting its potential for targeted application.